Financials Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi Anonim Sirketi
Equities
SURGY
TRESRTE00023
Real Estate Development & Operations
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
54.25 TRY | -0.82% | -2.16% | +81.32% |
Valuation
Fiscal Period: December | 2023 |
---|---|
Capitalization 1 | 5,012 |
Enterprise Value (EV) 1 | 4,553 |
P/E ratio | - |
Yield | - |
Capitalization / Revenue | - |
EV / Revenue | - |
EV / EBITDA | 4.83 x |
EV / FCF | 27,137,726 x |
FCF Yield | 0% |
Price to Book | - |
Nbr of stocks (in thousands) | 167,500 |
Reference price 2 | 29.92 |
Announcement Date | 5/2/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2022 | 2023 |
---|---|---|
Net sales | - | - |
EBITDA 1 | -64.07 | 942.5 |
EBIT 1 | -64.09 | 942 |
Operating Margin | - | - |
Earnings before Tax (EBT) 1 | 851.7 | 909.1 |
Net income 1 | 680.7 | 909.1 |
Net margin | - | - |
EPS | - | - |
Free Cash Flow | - | 167.8 |
FCF margin | - | - |
FCF Conversion (EBITDA) | - | 17.8% |
FCF Conversion (Net income) | - | 18.46% |
Dividend per Share | - | - |
Announcement Date | 12/1/23 | 5/2/24 |
Balance Sheet Analysis
Fiscal Period: December | 2022 | 2023 |
---|---|---|
Net Debt 1 | - | - |
Net Cash position 1 | 0.83 | 458 |
Leverage (Debt/EBITDA) | - | - |
Free Cash Flow | - | 168 |
ROE (net income / shareholders' equity) | - | 29.2% |
ROA (Net income/ Total Assets) | - | 15.2% |
Assets 1 | - | 5,995 |
Book Value Per Share 2 | 9.490 | - |
Cash Flow per Share 2 | 0.0100 | - |
Capex 1 | 0.23 | - |
Capex / Sales | - | - |
Announcement Date | 12/1/23 | 5/2/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+81.32% | 282M | |
-10.83% | 26.36B | |
+1.43% | 25.9B | |
+12.29% | 24.19B | |
+35.85% | 21.26B | |
+7.12% | 20.63B | |
-3.28% | 18.43B | |
+3.23% | 16.74B | |
+34.62% | 16.42B | |
+1.04% | 15.04B |
- Stock Market
- Equities
- SURGY Stock
- Financials Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi Anonim Sirketi